Home Sellers Question Commission Rates PostNAR Settlement Will the 6 Standard Shift MIDD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues FSLY Q1 2026 Earnings EPS Surges Past Estimates with 5834 Beat Stock Declines 421 Erdoan Visits Astana as Turkey and Kazakhstan Target 13 Billion in Bilateral Trade Employers Holdings Inc EIG Q1 2026 Earnings Modest EPS Beat Amid Solid Underwriting Performance